Thursday, November 20, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Dell Shares Tumble Following Analyst Downgrade

Robert Sasse by Robert Sasse
November 20, 2025
in AI & Quantum Computing, Analysis, Tech & Software
0
Dell Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Investors in Dell Technologies faced a significant setback as the company’s stock price declined sharply this week. The downturn was triggered by a substantial rating downgrade from financial services firm Morgan Stanley, which has raised questions about the technology manufacturer’s growth trajectory and its ambitious artificial intelligence initiatives.

Wall Street Divided on Tech Giant’s Prospects

The investment community appears deeply split on Dell’s outlook. While Morgan Stanley took a decidedly bearish stance, other major financial institutions maintain optimistic positions. JPMorgan Chase actually increased its price target to $170 while reaffirming its “Overweight” rating. Similarly, Evercore ISI projects the stock could reach $180 per share.

This stark divergence of opinion highlights the ongoing debate among market experts regarding Dell’s ability to navigate current challenges while capitalizing on emerging opportunities in the artificial intelligence sector.

Morgan Stanley’s Pessimistic Assessment

Morgan Stanley executed a dramatic reversal in its evaluation of Dell, implementing a dual downgrade from “Overweight” to “Underweight.” Even more consequential was the firm’s decision to slash its price target from $144 to $110 per share.

According to the analysts’ assessment, rising memory component expenses will substantially compress profit margins for the hardware manufacturer. Their projections indicate a margin contraction of 150 to 220 basis points for fiscal year 2027. Consequently, earnings per share forecasts have been reduced by approximately 12 percent.

Should investors sell immediately? Or is it worth buying Dell?

The research specifically highlighted challenges in Dell’s memory-intensive hardware divisions, which are expected to face pressure from increased DRAM and NAND costs over the coming 12 to 18 months.

Strategic Focus on Artificial Intelligence

Despite these immediate concerns, Dell continues to advance its artificial intelligence strategy without deviation. The company is strengthening its collaboration with NVIDIA while expanding its “AI Factory” product offerings.

The organization’s ambitious targets appear substantial, with expectations for AI server revenue to exceed $20 billion by 2026. This projection is supported by a considerable order backlog valued at $11.7 billion.

The critical question facing investors is whether this aggressive push into artificial intelligence can sufficiently offset the margin compression resulting from higher memory costs. Market participants may receive preliminary answers when Dell discloses quarterly results on November 25, though investor anxiety will likely persist until then.

Ad

Dell Stock: Buy or Sell?! New Dell Analysis from November 20 delivers the answer:

The latest Dell figures speak for themselves: Urgent action needed for Dell investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 20.

Dell: Buy or sell? Read more here...

Tags: DELL
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Bionxt Solutions Stock
Analysis

BioNxt Solutions Secures Key Patent Protection Across Eurasian Markets

November 20, 2025
Nestle Stock
Analysis

Nestlé Shares Secure Crucial Legal and Strategic Wins

November 20, 2025
aTyr Pharma Stock
Analysis

aTyr Pharma Shares Plummet Following Clinical Trial Failure

November 20, 2025
Next Post
Pinduoduo Stock

Pinduoduo Shares Face Growth Headwinds as Core Business Shows Strain

Microsoft Stock

Microsoft Shares Face Headwinds as Growth Strategy Comes Under Scrutiny

SQM Stock

SQM Shares Surge as Lithium Demand Reaches Fever Pitch

Recommended

Eli Lilly and Stock

Eli Lilly Shares Surge as Analysts Boost Ratings

1 month ago
Consumer Portfolio Services Stock

Subprime Auto Lender CPSS Sees Sharp Single-Day Rally Amid Longer-Term Decline

1 month ago
Finance_Financialization

Analyst Ratings and Price Targets for Advance Auto Parts A Breakdown

2 years ago
Blackstone Stock

Blackstone’s Strategic Expansion Across Multiple Fronts Signals Growth Phase

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Diginex Shares Surge on Strategic Partnership Announcement

Cardano’s Institutional Surge: Whales Drive Market Momentum

aTyr Pharma Shares Plummet Following Clinical Trial Failure

Pfizer’s BioNTech Divestment Sends Shockwaves Through Markets

Coinbase’s Strategic Expansion Meets Insider Selling Pressure

Lockheed Martin Shares: Poised for a Breakout?

Trending

Redcare Pharmacy Stock
E-Commerce

Redcare Pharmacy Stock Finds Hope with Key Amazon Hire

by Andreas Sommer
November 20, 2025
0

After a punishing year that saw its value cut in half, Redcare Pharmacy shares are attracting renewed...

Bionxt Solutions Stock

BioNxt Solutions Secures Key Patent Protection Across Eurasian Markets

November 20, 2025
Nestle Stock

Nestlé Shares Secure Crucial Legal and Strategic Wins

November 20, 2025
Diginex Stock

Diginex Shares Surge on Strategic Partnership Announcement

November 20, 2025
Cardano Stock

Cardano’s Institutional Surge: Whales Drive Market Momentum

November 20, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Redcare Pharmacy Stock Finds Hope with Key Amazon Hire
  • BioNxt Solutions Secures Key Patent Protection Across Eurasian Markets
  • Nestlé Shares Secure Crucial Legal and Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com